Alogliptin( Alogliptin )

Catalog No. M17613 CAS No. 850649-61-5

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

Alogliptin
Note

Research use only, not for human use.
Brief Description

Alogliptin(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9.
Description

Alogliptin is a DPP-4 inhibitor used for the treatment of Type 2 diabetes. Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of causing hypoglycemia, and exhibits relatively modest glucose-lowering activity. Alogliptin and other gliptins are commonly used in combination with metformin in patients whose diabetes cannot adequately be controlled with metformin alone.
In Vitro

——
In Vivo

——
Synonyms

Alogliptin
Pathway

Chromatin/Epigenetic
Target

Sirtuin
Recptor

DPP-4
Research Area

Metabolic Disease
Indication

——

CAS Number

850649-61-5
Formula Weight

339.39
Molecular Formula

C18H21N5O2
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 100 mg/mL (294.65 mM)
SMILES

CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=CC=CC=C2C#N)C1=O
Chemical Name

(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile

1. Feng J, et al. J Med Chem, 2007, 50(10), 2297-2300.

Calculator

molnova catalog